Interleukin-20 is involved in dry eye disease and is a potential therapeutic targetHsiao-Hsuan Wang(National Cheng Kung University), Ming‐Shi Chang(National Cheng Kung University)Journal of Biomedical ScienceJune 9, 202210.1186/s12929-022-00821-2Cited by 59SaveCiteExport RISWatch citationsRelated PapersAnti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis|PLoS ONE|2017|27IL‐20 is involved in obesity by modulation of adipogenesis and macrophage dysregulation|Immunology|2021|27Anti-IL-20 Monoclonal Antibody Suppresses Prostate Cancer Growth and Bone Osteolysis in Murine Models|PLoS ONE|2015|19